Incyte Corp (INCY)

May 09, 2025

New Incyte Suit Targets Broader Apotex Bid to Sell Jakafi Rival - Bloomberg Law News

May 09, 2025

May 09, 2025

Sun shines on Leqselvi at Federal Circuit - BioWorld MedTech

May 09, 2025

May 09, 2025

Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire Inc.

May 09, 2025

May 08, 2025

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 7, 2025 - BioSpace

May 08, 2025

May 07, 2025

Fed. Circ. Clears Way For Sun Pharma Alopecia Drug - Law360

May 07, 2025

May 07, 2025

US panel, finding no irreparable harm, vacates injunction against Sun Pharma - MLex

May 07, 2025

May 07, 2025

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | INCY Stock News - GuruFocus

May 07, 2025

May 07, 2025

Incyte Can’t Keep Sun’s Hair Drug Off Market, Appeals Court Says - Bloomberg Law News

May 07, 2025

May 07, 2025

Incyte Reports Strong Q1 2025 Financial Results and Pipeline Progress - MyChesCo

May 07, 2025

May 05, 2025

Chronic Hand Eczema Pipeline 2025: FDA Approvals, Therapies, - openPR.com

May 05, 2025

May 05, 2025

Novartis, Incyte Settle Drug Royalty Fight On Eve Of Trial - Law360

May 05, 2025

May 02, 2025

Incyte expects minimal tariff hit, lifts blood cancer drug's 2025 forecast - MSN

May 02, 2025

May 01, 2025

Polycythemia vera Market: Epidemiology, Therapies, - openPR.com

May 01, 2025

May 01, 2025

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com

May 01, 2025

May 01, 2025

Incyte to Present at Upcoming Investor Conference - Business Wire

May 01, 2025

May 01, 2025

Incyte (INCY) Target Price Raised Following Strong Q1 Performanc - GuruFocus

May 01, 2025

Apr 30, 2025

9 Analysts Have This To Say About IncyteIncyte (NASDAQ:INCY) - Benzinga

Apr 30, 2025

Apr 30, 2025

Incyte (INCY) Target Price Raised Following Strong Q1 Performance | INCY Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

Incyte (INCY) Receives Adjusted Price Target from TD Cowen | INC - GuruFocus

Apr 30, 2025

Apr 30, 2025

BofA Boosts Incyte (INCY) Price Target Following Q1 Results | IN - GuruFocus

Apr 30, 2025

Apr 30, 2025

Incyte (INCY) Target Price Raised by Wells Fargo Despite Mixed R - GuruFocus

Apr 30, 2025

Apr 30, 2025

Steroid Refactory Acute Graft-Versus-Host Disease Market Growth Projections 2023-2032: DelveInsight Analysis | MaaT Pharma, Medac GmbH, AltruBio Inc., Incyte Corporation - Barchart.com

Apr 30, 2025

Apr 30, 2025

Incyte Corporation (NASDAQ:INCY) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025

Apr 30, 2025

Incyte: Q1 Earnings Snapshot - CT Insider

Apr 30, 2025

Apr 30, 2025

Incyte Corp (INCY) Q1 2025 Earnings Call Highlights: Robust Reve - GuruFocus

Apr 30, 2025

Apr 30, 2025

Incyte Corp (INCY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Incyte to Showcase Latest Oncology Advancements at 2025 ASCO Meeting - MSN

Apr 30, 2025

Apr 29, 2025

Earnings call transcript: Incyte Q1 2025 beats expectations, stock rises - Investing.com

Apr 29, 2025

Apr 29, 2025

BofA raises Incyte stock price target to $89, maintains Buy rating - Investing.com

Apr 29, 2025

Apr 29, 2025

Earnings call transcript: Incyte Q1 2025 beats expectations, stock rises By Investing.com - Investing.com Canada

Apr 29, 2025

Apr 29, 2025

INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales - The Globe and Mail

Apr 29, 2025

Apr 29, 2025

Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs - BioSpace

Apr 29, 2025

Apr 29, 2025

Incyte Corp Raises Jakafi Sales Forecast Following Strong Performance - Finimize

Apr 29, 2025

Apr 29, 2025

Incyte (INCY) Surpasses Q1 Revenue Expectations, Driven by Key P - GuruFocus

Apr 29, 2025

Apr 29, 2025

Incyte Corp reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 29, 2025

Apr 29, 2025

Incyte Q1 2025 slides: 26% product revenue growth, Jakafi guidance raised - Investing.com

Apr 29, 2025

Apr 29, 2025

Incyte Corp (INCY) Q1 2025 Earnings: EPS of $0.80 Beats Estimate, Revenue Surges to $1.053 Billion - GuruFocus

Apr 29, 2025

Apr 29, 2025

Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs | INCY Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Incyte Q1 Results Top Estimates - Nasdaq

Apr 29, 2025

Apr 29, 2025

Incyte (INCY) Surpasses Q1 Revenue Expectations, Driven by Key Products | INCY Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Incyte earnings beat by $0.12, revenue topped estimates - Investing.com

Apr 29, 2025

Apr 29, 2025

Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers - Barchart.com

Apr 29, 2025

Apr 29, 2025

Incyte Reports 2025 First Quarter Financial Results - TradingView

Apr 29, 2025

Apr 29, 2025

Incyte (INCY) Set to Announce Q1 Earnings, Analysts Cautious - GuruFocus

Apr 29, 2025